Targeted therapies in systemic lupus erythematosus: mechanistic insights and clinical evidence from phase II and III trials
A systematic review of multicentre, randomised, placebo or standard of care-controlled phase II and phase III clinical trials investigating novel targeted and biological therapies in patients with SLE finds emerging therapies directed at specific immune pathways offer the potential to reduce disease activity, minimise...